3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Melanoma
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
Carcinoma, Renal Cell
6
Kidney Neoplasms
4
Leukemia, Myeloid, Chronic-Phase
3
Carcinoma, Hepatocellular
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Polycythemia Vera
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Leukemia
2
Hepatitis B, Chronic
2
Fallopian Tube Neoplasms
2
Brain Neoplasms
2
Uveal Melanoma
1
Thrombocytosis
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Osteosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplasms
1
Interventions
Ifosfamide
30
Methotrexate
27
Doxorubicin
25
Cyclophosphamide
24
Cisplatin
22
Filgrastim
18
Etoposide
17
Gemcitabine
16
Leucovorin
14
Magnetic Resonance Spectroscopy
11
Temozolomide
10
cabozantinib
9
apatinib
9
Specimen Handling
9
Carboplatin
9
fludarabine
8
X-Rays
8
Nivolumab
8
Neoadjuvant Therapy
8
Irinotecan
8
Granulocyte Colony-Stimulating Factor
8
Docetaxel
8
Zoledronic Acid
7
Vincristine
7
Sirolimus
7
Radiotherapy
7
Phantoms, Imaging
7
Biopsy
7
Topotecan
6
Mesna
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Osteosarcoma
×
peginterferon alfa-2b
×
Clear all
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts